1 Dec, 16 | by flee
The ACR congress also featured, as it always does, a lot of exciting activities and new findings on SLE. Lupus gives up its secrets only very slowly, but there were many presentations from researchers working on elucidating the etiology and pathophysiology of this disease. I was most impressed by results from different groups that point at potentially important roles for extracellular vesicles in SLE. I was also pleased to see how many clinical researchers were analyzing the prevalence of remission in SLE using a newly developed framework. There were no major new therapeutic successes reported at this congress, but there is high anticipation for the continuation of the earlier promising results with therapeutics that target the interferon pathway. For me, another highlight was the Editorial Board meeting for the still young open-access journal Lupus Science and Medicine. Together with Dr. Jill Buyon from New York I have the honor of being editor for this publication, which is supported by a partnership between the Lupus Foundation of America and the BMJ publishing group. We are now entering our third year and the Editorial Board unanimously felt that the journal has had a most exciting and promising development, with more than 170 manuscripts submitted and many very interesting and often cited results having been published already in this short time.